Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Laight BJ, Harper D, Dmytryk N, Zhang CS, et al. Cancer Res 2025;85:2643-2658.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Laight BJ, Harper D, Dmytryk N, Zhang CS, et al. Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer Res 2025;85:2643-2658.
PMID: 40299778